TAMARA CLOUSE: Open Payments
NPI 1699081208 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 59 payments from 13 companies in 2025. Trend: 2023 $264 · 2024 $1,261 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $443 |
| AstraZeneca Pharmaceuticals LP | 4 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Lilly USA, LLC | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $38 |
| Grifols USA, LLC | 1 | $33 |
| Novo Nordisk Inc | 2 | $29 |
| Ardelyx, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, AIRSUPRA, CAPLYTA, JARDIANCE, UBRELVY, VOQUEZNA, MOUNJARO.
Industry payments across NE — which companies pay providers there.
